Patents by Inventor Katsuya Kishikawa

Katsuya Kishikawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Piperidine derivatives and agent comprising the derivative as active ingredient
    Patent number: 7649095
    Abstract: Piperidine derivatives represented by formula (I) or nontoxic salts thereof (wherein symbols are defined in the description): Since the compound represented by formula (I) has a PDE4 inhibitory activity, it is useful for preventing and/or treating inflammatory diseases, diabetic diseases, allergic diseases, autoimmune diseases, osteoporosis, bone fracture, obesity, depression, Parkinson's disease, dementia, ischemia-reperfusion injury, leukemia and the like.
    Type: Grant
    Filed: April 12, 2006
    Date of Patent: January 19, 2010
    Assignee: Ono Pharmaceutical Co., Ltd.
    Inventors: Hisao Nakai, Katsuya Kishikawa
  • Use of sphingosine 1-phosphate as active ingredient for the treatment of pulmonary fibrosis
    Patent number: 7151093
    Abstract: An anti fibrotic agent, comprising a sphingosine 1-phosphate (S1P) receptor agonist or sphingosine 1-phosphate (S1P) as an active ingredient. Since an S1P receptor agonist, particularly S1P, has activity of inhibiting fibrosis in various organs, it is useful in preventing and/or treating diseases caused by fibrosis in organs, such as pulmonary fibrosis, interstitial pneumonia, chronic hepatitis, hepatic cirrhosis, chronic renal failure, renal glomerulosclerosis, etc.
    Type: Grant
    Filed: September 15, 2003
    Date of Patent: December 19, 2006
    Assignee: Ono Pharmaceutical Co., Ltd.
    Inventors: Katsuya Kishikawa, Shigeru Matsumoto
  • Anti fibrotic agent containing sphingosine 1-phosphate receptor agonist or sphingosine 1-phosphate as active ingredient
    Publication number: 20060281709
    Abstract: An anti fibrotic agent, comprising a sphingosine 1-phosphate (S1P) receptor agonist or sphingosine 1-phosphate (S1P) as an active ingredient. Since an S1P receptor agonist, particularly S1P, has activity of inhibiting fibrosis in various organs, it is useful in preventing and/or treating diseases caused by fibrosis in organs, such as pulmonary fibrosis, interstitial pneumonia, chronic hepatitis, hepatic cirrhosis, chronic renal failure, renal glomerulosclerosis, etc.
    Type: Application
    Filed: August 25, 2006
    Publication date: December 14, 2006
    Inventors: Katsuya Kishikawa, Shigeru Matsumoto
  • Piperidine derivatives and agent comprising the derivative as active ingredient
    Patent number: 7109342
    Abstract: Piperidine derivatives represented by formula (I) or nontoxic salts thereof (wherein symbols are defined in the description): Since the compound represented by formula (I) has a PDE4 inhibitory activity, it is useful for preventing and/or treating inflammatory diseases, diabetic diseases, allergic diseases, autoimmune diseases, osteoporosis, bone fracture, obesity, depression, Parkinson's disease, dementia, ischemia-reperfusion injury, leukemia and the like.
    Type: Grant
    Filed: August 9, 2001
    Date of Patent: September 19, 2006
    Assignee: Ono Pharmaceutical Co., Ltd.
    Inventors: Hisao Nakai, Katsuya Kishikawa
  • Piperidine derivatives and agent comprising the derivative as active ingredient
    Publication number: 20060189656
    Abstract: Piperidine derivatives represented by formula (I) or nontoxic salts thereof (wherein symbols are defined in the description): Since the compound represented by formula (I) has a PDE4 inhibitory activity, it is useful for preventing and/or treating inflammatory diseases, diabetic diseases, allergic diseases, autoimmune diseases, osteoporosis, bone fracture, obesity, depression, Parkinson's disease, dementia, ischemia-reperfusion injury, leukemia and the like.
    Type: Application
    Filed: April 12, 2006
    Publication date: August 24, 2006
    Inventors: Hisao Nakai, Katsuya Kishikawa
  • Anti fibrotic agent containing sphingosine 1-phosphate receptor agonist or sphingosine 1-phospate as active ingredient
    Publication number: 20040063667
    Abstract: An anti fibrotic agent, comprising a sphingosine 1-phosphate (S1P) receptor agonist or sphingosine 1-phosphate (S1P) as an active ingredient. Since an S1P receptor agonist, particularly S1P, has activity of inhibiting fibrosis in various organs, it is useful in preventing and/or treating diseases caused by fibrosis in organs, such as pulmonary fibrosis, interstitial pneumonia, chronic hepatitis, hepatic cirrhosis, chronic renal failure, renal glomerulosclerosis, etc.
    Type: Application
    Filed: September 15, 2003
    Publication date: April 1, 2004
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Katsuya Kishikawa, Shigeru Matsumoto
  • Piperidine derivatives and drugs containing these derivatives as active ingredient
    Publication number: 20040044036
    Abstract: Piperidine derivatives represented by formula (I) or nontoxic salts thereof (wherein symbols are defined in the description): 1
    Type: Application
    Filed: September 2, 2003
    Publication date: March 4, 2004
    Inventors: Hisao Nakai, Katsuya Kishikawa